NewslettersCancer Stem Cell NewsIovance’s AMTAGVI™ (lifileucel) Receives US FDA Accelerated Approval for Advanced MelanomaBy Noshin Noorjahan - February 21, 2024078Iovance Biotherapeutics, Inc. announced that the US FDA has approved AMTAGVI™ suspension for intravenous infusion.[nan]Press Release